Barrett’s Esophagus — Patient Information
A clear guide for Valley Gastroenterology patients.
What is Barrett’s esophagus?
Barrett’s esophagus is a change in the lining of the lower esophagus caused by long‑standing acid reflux (GERD). Under the microscope, the normal lining is replaced with a different type of tissue (intestinal metaplasia). Barrett’s itself is not cancer, but it can increase the risk of developing esophageal cancer over time.
Who is at risk?
  • Long‑standing or frequent GERD symptoms
  • Age >50, male, central obesity, tobacco use
  • Family history of Barrett’s or esophageal cancer
Many people with Barrett’s have few or no symptoms—screening may be considered in higher‑risk patients with chronic GERD.
Symptoms & red flags
Common: heartburn, regurgitation, chest discomfort, trouble swallowing with solids
Call us promptly for: progressive dysphagia, unintentional weight loss, vomiting, bleeding (black/tarry stools), or persistent chest pain (seek urgent care/ER if severe or concerning for heart).
How is it diagnosed?
  • Upper endoscopy (EGD) with biopsies confirms Barrett’s and checks for dysplasia (precancerous changes).
  • If Barrett’s is confirmed, we assign a grade:
  • No dysplasia
  • Indefinite for dysplasia (often re‑check after optimizing acid control)
  • Low‑grade dysplasia (LGD)
  • High‑grade dysplasia (HGD)
Treatment & follow‑up
All patients
  • Acid control: usually a proton pump inhibitor (PPI) taken 30–60 minutes before breakfast (and before dinner if twice‑daily). We tailor dose/duration.
  • Lifestyle: weight management, elevate head of bed, avoid late meals, stop tobacco, limit triggers (varies by person).
If no dysplasia
  • Surveillance endoscopy at intervals recommended by your clinician to monitor for changes.
If low‑grade dysplasia
  • Options include endoscopic eradication therapy (commonly radiofrequency ablation [RFA] ± EMR for visible lesions) or close surveillance. We’ll review benefits and risks.
If high‑grade dysplasia or early cancer
  • Endoscopic eradication therapy (EMR/ESD and ablation) is often first‑line; surgery is rarely needed. Managed in coordination with our advanced endoscopy and oncology partners.
After successful eradication, ongoing surveillance is still needed to ensure durable control.
Living with Barrett’s
  • Take PPIs as directed; don’t stop without a plan
  • Maintain a healthy weight and active lifestyle
  • Limit alcohol; avoid tobacco/nicotine
  • Keep routine follow‑ups and surveillance on schedule
FAQs
Do PPIs prevent cancer? They reduce acid injury and may lower progression risk; surveillance is still important.
Will I need surgery? Most patients are managed with medications and endoscopic therapy. Surgery is uncommon and reserved for select cases.
Can reflux surgery (e.g., fundoplication) help? It can control reflux symptoms; decisions are individualized and do notreplace the need for surveillance.
Alaska‑specific note
We accommodate winter travel and weather‑related rescheduling without penalty. Telehealth is available for many visits; procedures require in‑person care.
Next steps
If you have chronic GERD or risk factors, schedule a consult to discuss whether screening endoscopy is appropriate. If you’ve already been diagnosed with Barrett’s, we’ll create a personalized surveillance and treatment plan.
Valley Gastroenterology
3190 E Meridian Park Loop, Suite 206
Wasilla, Alaska 99654
Phone: (907) 373-2544
Fax: (844) 689-4240
Web: ValleyGastroAK.com